SA, H., N, A., BA, D., A, S., C, E., JR, C., . . . HC, D. (2020). Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study. Journal of hepatology, 72(4), 613. https://doi.org/10.1016/j.jhep.2019.10.023
Chicago Style (17th ed.) CitationSA, Harrison, et al. "Insulin Sensitizer MSDC-0602K in Non-alcoholic Steatohepatitis: A Randomized, Double-blind, Placebo-controlled Phase IIb Study." Journal of Hepatology 72, no. 4 (2020): 613. https://doi.org/10.1016/j.jhep.2019.10.023.
MLA (9th ed.) CitationSA, Harrison, et al. "Insulin Sensitizer MSDC-0602K in Non-alcoholic Steatohepatitis: A Randomized, Double-blind, Placebo-controlled Phase IIb Study." Journal of Hepatology, vol. 72, no. 4, 2020, p. 613, https://doi.org/10.1016/j.jhep.2019.10.023.